CSIMarket
 


Invo Bioscience Inc   (INVO)
Other Ticker:  
 

Cumulative Invo Bioscience Inc 's Working Capital Ratio for Trailing Twelve Months Period

INVO's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

INVO Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth 241.11 % 324.36 % 417.51 % 208.22 % -29.55 %
Y / Y Current Assets Growth 90.15 % -66.95 % -36.45 % -90.15 % -82.32 %
Working Capital Ratio for Trailing Twelve Months Period 0.36 0.39 0.68 1.31 3.25
Total Ranking # 3617 # 3810 # 3764 # 3619 # 1769
Seq. Current Liabilities Growth 9.28 % 0.43 % 40.03 % 121.94 % 35.96 %
Seq. Current Assets Growth 112.77 % -70.03 % 352.39 % -34.09 % -63.02 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $5 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 0.36 below Invo Bioscience Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 206 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Invo Bioscience Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about INVO
Working Capital Ratio INVO in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 207
Sector # 971
S&P 500 # 3597


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.96 2.02 0.35
(Dec 31 2021)   (Sep 30 2023)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Interpace Biosciences Inc   0.90 
Carmell Corporation  0.90 
Viveve Medical Inc   0.89 
Allurion Technologies Inc   0.85 
Vivos Therapeutics Inc   0.79 
T2 Biosystems Inc   0.74 
Biosig Technologies Inc   0.68 
Renovacare Inc   0.62 
Envoy Medical Inc   0.61 
Sep Acquisition Corp   0.60 
Biotricity Inc   0.60 
Spectral Ai Inc   0.59 
P3 Health Partners Inc   0.58 
Nemaura Medical Inc   0.58 
Guided Therapeutics Inc   0.51 
Regenicin Inc   0.51 
Bioplus Acquisition Corp   0.49 
Bellevue Life Sciences Acquisition Corp   0.47 
Uphealth Inc   0.46 
Electromedical Technologies Inc  0.40 
Vystar Corporation  0.39 
Northview Acquisition Corp   0.37 
Yubo International Biotech Limited  0.31 
Invo Bioscience Inc   0.30 
Arch Therapeutics Inc   0.29 
G Medical Innovations Holdings Ltd   0.22 
Non Invasive Monitoring Systems Inc  0.21 
Nu med Plus Inc   0.21 
Aurora Technology Acquisition Corp   0.18 
Todos Medical Ltd   0.18 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com